GLIPTADIN SITAGLIPTIN Dipeptidyl Peptidase 4 Inhibitor Film Coated Tablet 100mg Sold Per Piece [PRESCRIPTION REQUIRED]

Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. It can also be used in combination with metformin, sulfonylurea, PPARy agonist, metformin and sulfonylurea, metformin and a PPARy agonist, and insulin, to improve glycemic control in patients with type 2 diabetes mellitus

Place of Origin

Philippines

Product Usage

Sitagliptin has a recommended dose of 100 mg once daily as monotherapy or as combination therapy with metformin, a sulfonylurea, insulin (with or without metformin), a PPARy agonist (e.g., thiazolidinediones), metformin plus a sulfonylurea, or metformin plus PPARy agonist. When it is used in combination with a sulfonylurea or with insulin, a lower dose of sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea-or insulin-induced hypoglycemia.

Ingredients

"Each Film-Coated tablet contains: Sitagliptin (as phosphate monohydrate) ..........100 mg"

Width

7.5

Height

4.5

Depth

10.2